We previously reported that NCTD has multiple antitumor activities against gallbladder cancers, while tissue inhibitor of matrix metalloproteinase-2 (TIMP-2, a 21-kDa protein and VM inhibitor) has anti-VM activity for these cancers [39]-[42]. The gene discussed is TIMP2; the disease is cancer.